The fundamental differences in the phenotype of moderate COVID-19 monocytes compared to that of healthy individuals led us to investigate in depth the gene expression profile of ex vivo isolated classical CD14+ monocytes from patients with moderate COVID-19 and compare them with those of healthy individuals (Fig. 2). The gene discussed is CD14; the disease is COVID-19.